Marsh (MRSH) cleared the bar on both lines in the third quarter. Adjusted EPS of $2.03 beat the $1.96 consensus by 3.6%, and revenue of $6.863 billion topped the $6.63 billion estimate by 3.5%. Adjusted EPS rose 10% from $1.85, extending a steady build from 8% growth in the first quarter and 9% in the second. Reported revenue grew 8%, or 5% on an underlying basis. The central tension is that the parts of the business management is leaning into are accelerating, while profitability, reinsurance and the source of some growth all argue for a more measured reading than the double-digit EPS headline suggests.
The quality of the beat deserves scrutiny. Adjusted net income grew about 7%, to $972 million from $911 million. Diluted shares fell to 479 million from 494 million, so buybacks did a meaningful share of the work in reaching 10% EPS growth. Adjusted operating margin was flat at 22.7%, even though the full-year outlook calls for expansion. On a GAAP basis, operating income rose only 4%, GAAP operating margin slipped to 17.7% from 18.4%, and diluted EPS was $1.69. Results absorbed a $144 million Greensill charge and $79 million of restructuring costs. Those charges were partly offset by a $126 million gain on consolidating Deasterra Partners, and that gain is booked in revenue. Underlying growth of 5%, rather than the 8% headline, is the better gauge of the top line, since acquisitions added roughly three points. Cash generation also softened. Nine-month operating cash flow fell to $2.31 billion from $3.13 billion as receivables swelled. The company issued $1.6 billion of commercial paper during a year in which it has spent $2.0 billion on repurchases.
Beneath the consolidated numbers, the call showed real operating momentum. Marsh Risk underlying growth improved to 5% from 4% in each of the first two quarters. International rose 6% and EMEA 7%, a notable result with global commercial rates still down 5% and property down 10%. Management Consulting grew 14%, up from 13% in the second quarter and 6% in the first, and well above the mid-to-high single-digit pace management had guided for the quarter. AI-related work was cited as a driver. Health and Benefits rebounded to 5% from 3%, and assets under management reached $843 billion, up 23% year over year. Management's tone was noticeably more confident, framing AI as an active growth engine rather than a threat.
Bears still have legitimate ammunition. Reinsurance underlying revenue fell 6%, continuing a slide from +2% in the first quarter and -2% in the second. Management expects soft property-catastrophe conditions to persist through the January 1 renewals, a difficult setup for a book overweight property cat and the U.S. Part of the consulting outperformance came from success fees pulled forward from the fourth quarter, which implies roughly flat consulting growth there. Workforce and Rewards slipped 1% on Middle East disruption, and fiduciary interest income keeps eroding, with roughly $94 million guided for the fourth quarter.
The forward-looking catalysts were substantive. Marsh raised its Thrive savings target to $600 million from $400 million, while lifting expected program costs to about $750 million from roughly $500 million. That trade-off puts more near-term charges against a larger efficiency payoff, with actions largely complete by the end of 2028. Management said the Greensill litigation is settled with no further charges expected, which removes an overhang that cost $425 million in the first quarter alone. Marsh also launched Stratus Exchange, offering up to $10 billion of property capacity for operational data centers, and Broker Workbench for U.K. wholesale. It held capital deployment guidance at $5.5 billion and completed its brand transition ahead of schedule.
The market setup is more complicated than the surprise implies. Shares hit a 52-week high of $198.49 on July 29, shortly after the prior report. They then slid to an inter-earnings low of $166.48 on October 7 before recovering to $178.40 heading into the release. That leaves the stock down 4.4% since the open following the July report and 10.1% below the high, though still 2.3% above its 200-day moving average. Investor sentiment improved from essentially neutral (-0.005) to modestly positive (0.124), a measurable but not exuberant shift. The trend readings are mixed, with momentum neutral and AVWAP still negative.
The bottom line is that Marsh delivered a credible beat backed by accelerating Risk and consulting growth, a bigger efficiency program and the removal of the Greensill overhang. However, flat margins, buyback-assisted EPS growth, weaker cash flow, pulled-forward consulting fees and a deteriorating reinsurance cycle mean the quarter's quality is good rather than pristine. Investors who sold the stock off its summer high will want evidence that Risk's acceleration can outrun the reinsurance drag through year-end renewals.